Skip to content
Screener

IBEX Limited IBEX Stock Issued During Period, Value, Stock Options Exercised

Stock Issued During Period, Value, Stock Options Exercised at other companies

Genpact logo
GenpactG
$0
ExlService Holdings logo
ExlService HoldingsEXLS

Other financials

Income statement

See full
Revenue$164.4M+16.8%
Gross profit$48.8M+9.1%
Operating income$16.2M+21.2%
Net income$13.3M+27.3%
EPS (diluted)$0.89+21.9%

Balance sheet

See full
Cash & equivalents$15.4M+18.7%
Total debt$63.2M-44.1%
Total equity$160.8M+29.5%
Total assets$297.2M+8.2%

Cash flow

See full
Operating cash flow$11.9M+34.4%
CapEx$5.3M+0.1%
Free cash flow$6.6M+85.1%

Valuation

See full
Market cap$495.53M+29.1%
Enterprise value$543.36M+23.3%
P/E10.5×+0.1×
P/S0.8×+0.1×

Profitability

See full
Gross margin29.9%-1.0pp
Operating margin9.2%+0.3pp
Net margin7.5%+0.6pp
FCF margin5.3%+2.8pp

Returns & leverage

See full
Return on equity33.1%+6.9pp
Debt / equity0.4×-0.5×
Current ratio+0.3×

Where this comes from

Reported directly by IBEX Limited in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised.

The source filing: IBEX Limited’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:27 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001720420-26-000011
Line itemCommon shares / SharesCommon shares / AmountTreasury Stock / AmountAdditional Paid-in CapitalAccumulated Other Comprehensive LossRetained EarningsTotal Stockholders'Equity
Net income13,32513,325
Foreign currency translation adjustment(1,123)(1,123)
Changes in fair value of cash flow hedges(1,679)(1,679)
Purchase of treasury shares(140)(4,553)(4,553)
Issuance of common shares200467467
Shares withheld related to net share settlement of equity awards(64)(2,261)(2,261)
Stock-based compensation expense2,0922,092
Balance, March 31, 202613,436$2$(113,446)$224,225$(13,323)$63,325$160,783

Item 1. Financial Statements

FAQ

What is IBEX Limited's stock issued during period, value, stock options exercised?
IBEX Limited (IBEX) reported stock issued during period, value, stock options exercised of $467K in Q1 2026.
How has IBEX Limited's stock issued during period, value, stock options exercised changed year-over-year?
IBEX Limited's stock issued during period, value, stock options exercised decreased by 83.4% year-over-year, from $2.81M to $467K.
What is the long-term trend for IBEX Limited's stock issued during period, value, stock options exercised?
Over 3 years (2022 to 2025), IBEX Limited's stock issued during period, value, stock options exercised has grown at a 397.4% compound annual growth rate (CAGR), from $35K to $4.31M.
What does stock issued during period, value, stock options exercised mean?
The total cash proceeds received by the company from the exercise of employee or director stock options. This metric indicates the level of equity-based compensation utilization and the resulting cash inflow from share issuance.

Ask your AI about IBEX Limited's stock issued during period, value, stock options exercised.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude